Itaconix plc · LSE:ITX
Itaconix — Investor Presentation (January 2018)
15 slides from Itaconix's investor presentation, Jan 25, 2018
Slide 1: Polymers for Better Living
Polymers for Better LivingTM Kevin Matthews, CEO 25th January 2018 Slide 1
Slide 2: Cautionary statement
Cautionary statement These presentation materials (the "Presentation Materials") have been prepared by Itaconix PLC (the "Company").The Presentation Materials do not constitute or form any part of any offer or invitation to sell or issue or purchase or subscribe for any shares in the Company nor sha
Slide 3: Itaconix - Bio-based Specialty Chemicals Business
Itaconix - Bio-based Specialty Chemicals Business Specialty Polymers; Unique Performance Ingredients Leader in bio-based polymers based on itaconic acid using an established proprietary process with break-through economics to produce unique or enhanced product performance at a competitive price. Tar
Slide 4: Sustainability – The Mega Trend of Our Generation
Sustainability – The Mega Trend of Our Generation Established Itaconix Partners AkzoNobel, Arkema, BASF, Bayer Clariant, DSM, DuPont, Evonik, Henkel, IFF, Lanxess, Solvay, Wacker Itaconix’s bio-based polymers are aligned with this global agenda, with products ideally positioned to play a significant
Slide 5: Market Seeks New Performance Ingredients
Market Seeks New Performance Ingredients Drivers of Change Itaconix patented products Safety / Regulations Products that are safer alternatives for humans and/or the environment Itaconix® DSP™ Phosphates replacement in laundry / dishwash Itaconix® CHT ™ Performance Improving consumer products Effici
Slide 6: Targeted Ingredient Segments
Targeted Ingredient Segments Product opportunities across a $30bn market space currently addressing identified market niches worth > $1.4bn Target Ingredient Markets Size of Potential Market Products Use 5 Water Soluble Polymers $30bn - composed of many niches ® Itaconix ZINADOR™ Homecare & Industri
Slide 7: Business Model
Business Model Core focus on products derived from itaconic acid using patent protected IP. Most significant challenge is scaling market access for current products and identifying niche applications where new products have a competitive advantage Primarily product based business, licence agreemen
Slide 8: Competitive Advantage
Competitive Advantage • Unique, differentiated product performance across a platform of product formats • Patented technology delivering breakthrough economics Processing Hours Better Polymerisation Rate and Yield 40 Cost/kg 30 Economically 20 viable 10 Major expansion of US facility in 2017: Bio-ba
Slide 9: Automatic Dishwash – Itaconix CHT
Automatic Dishwash – Itaconix® CHTTM Example: EU ADW Market opportunity • Most mature unit dose/pod market • 15bn unit doses p.a.: 50% brand; 50% private label • Anti-spotting • CHT value per pod = $0.004 • Estimated EU CHT potential: $60 million • Shine Partnership with AkzoNobel designed to Perfor
Slide 10: Haircare – Revcare NE
Haircare – RevcareTM NE Global distributor network established to address $130M market Product line extensions targeted to expand addressable market • Hair styling • Frizz control • Heat protection Products containing Itaconix ingredients Slide 10
Slide 11: Partnerships driving commercial expansion
Partnerships driving commercial expansion 2019 and beyond 2018 milestones 2017 • Chelates supply and joint Access global market via marketing agreement • Chelates JDA • First sales through AN AkzoNobel: • Performance Additives JDA • Repeat order shipped in December • End customer adoptions • R
Slide 12: Outlook – Poised for growth
Outlook – Poised for growth Market alignment - Significant drivers that align with bio-based ingredients Specialty polymers innovator – Winning customers and partners Validation of Product benefits: Unique or enhanced product performance at competitive cost Sustainable products Products launch
Slide 13: Appendix
Appendix Slide 13 Ita Caen IX
Slide 14: Experienced Board
Experienced Board Kevin Matthews (CEO) Robin Cridland (CFO) Internationally experienced public Experienced In Finance and M&A and private company director 20+ years of pharma/tech business Executive Experienced strategic leader with development, corporate development and strong commercial acumen. NE
Slide 15: Specialty Chemicals Market Characteristics
Specialty Chemicals Market Characteristics Key Attributes • Small % of final product – generally modest volumes • Performance enhancing properties – critical to performance of end product • Limited price sensitivity – high margin business • Low substitution rates – once designed in business is highl